Your BMI is 32. You have tried early-morning walks, sugar-free chai and the diet a cousin swore by, and the scale moved, then crept back. A FibroScan has now found fat in the liver, and the word “surgery” worries everyone at home. It is a common place to be: the ICMR-INDIAB national survey found generalised obesity in 28.6% of Indian adults and abdominal obesity in 39.5%.
Search for non-surgical weight loss in Noida and many results are slimming or cosmetic fat-reduction clinics. This guide compares the four medical routes: a structured lifestyle programme, weight-loss medicines, the intragastric balloon and endoscopic sleeve gastroplasty (ESG), with trial results, who qualifies and what happens afterwards.
Key Takeaways
- Medically, non-surgical weight loss means a lifestyle programme, prescription medicine or an endoscopic procedure done through the mouth, with no cuts on the abdomen.
- Average trial results: 13.6% of body weight at one year after ESG, nearly 15% at 68 weeks on weekly semaglutide, and 7-14% at 6-12 months with a balloon. Averages, not promises.
- A 2024 US-European guideline suggests endoscopic therapy at a BMI of 30 or more, or 27-29.9 with an obesity-related condition.
- For fatty liver, Indian liver guidance links 3-5% weight loss with less liver fat and 10% or more with less scarring.
- Weight tends to return when treatment stops.
What is non-surgical weight loss?
Definition: Non-surgical weight loss is the medical treatment of obesity without cutting or removing any part of the stomach or bowel. It covers a supervised diet-and-activity programme, prescription medicines, and endoscopic procedures, in which a flexible tube with a camera (an endoscope) is passed through the mouth to work inside the stomach.
Obesity here is a medical condition, measured by body-mass index (BMI: weight in kilograms divided by the square of height in metres) and waist size, and it travels with diabetes, high blood pressure and fatty liver. Cosmetic fat reduction is aimed at shape, not at those conditions. The endoscopic options use the same kind of instrument as a routine endoscopy; the bariatric endoscopy page describes the procedures themselves.
The four options side by side
The figures are averages from the trials and reviews themselves. Each study enrolled different people for different lengths of time, so read them as a rough guide, not a race.
| Option | How it works | Average weight loss in trials | How long | Main risks and limits |
|---|---|---|---|---|
| Structured lifestyle programme | Calorie deficit and regular activity, with follow-up | 0.8% at one year and 2.4% at 68 weeks (comparison groups of the ESG and semaglutide trials) | Lifelong | Few medical risks; depends on keeping it up |
| Weight-loss medicine (semaglutide 2.4 mg, weekly injection) | A GLP-1 based medicine that curbs appetite, used with lifestyle change | Nearly 15% at 68 weeks | Ongoing | Nausea and diarrhoea, usually mild and passing; 4.5% stopped for stomach side effects |
| Intragastric balloon | A soft balloon placed in the stomach by endoscopy and filled with saline or air | 7-14% at 6-12 months | 6-12 months depending on type, then removed by endoscopy | Nausea and vomiting led to early removal in 9% |
| Endoscopic sleeve gastroplasty (ESG) | Stitches placed from inside fold the stomach into a narrower sleeve; nothing is removed | 13.6% at one year | Stitches stay in place | ESG-related serious complications in 2% in the main trial |
The lifestyle figures come from trial comparison groups, and every other option was tested alongside diet and activity, not instead of them. Balloon prices vary with the balloon type and how long it stays; the intragastric balloon cost guide explains what moves the price.
Who qualifies for endoscopic weight loss?
A joint guideline from the US and European endoscopy societies suggests endoscopic bariatric therapy, with lifestyle change, for adults with a BMI of 30 or more, or 27 to 29.9 with at least one obesity-related condition such as diabetes or high blood pressure.
Indian adults need a slightly different lens. Indian liver guidance treats a BMI below 23 as normal for Indians, and Indian surgical guidance sets lower thresholds than Western ones. So the decision rests on BMI together with waist size, sugar, blood pressure and liver findings, not one number.
A balloon is not for everyone. A 2025 review lists previous stomach or bowel surgery, a bleeding tendency, stomach ulcers, a large hiatus hernia, active H. pylori infection and pregnancy as reasons not to place one.
Why weight loss matters for fatty liver
The INASL guidance on fatty liver disease (also called NAFLD, now renamed MASLD) describes a dose-response: weight loss of 3-5% is associated with less liver fat, 7% or more with less inflammation (steatohepatitis), and 10% or more with improvement in scarring (fibrosis). It recommends a 7-10% target for people who are overweight or obese, with diet and exercise as the primary route.
For someone who weighs 90 kg, that is roughly 6 to 9 kg. When diet and activity alone have not reached it, a medicine or an endoscopic procedure may help close the gap, and a repeat FibroScan, a non-invasive scan of liver fat and stiffness, shows how the liver has responded.
Which route suits which situation?
- BMI under 30 with fatty liver or early diabetes: a structured obesity management programme comes first, because small, steady losses already count for the liver.
- BMI 30-40, repeated diets have failed, a time-limited aid appeals: a balloon, with the plan for life after removal agreed before it goes in.
- BMI 30-40, wanting a longer-lasting change without surgery: ESG. In its main trial, 68% of those followed for two years still had at least a quarter of their excess weight off.
- Comfortable with long-term injections: medicine, on prescription and under supervision, never bought online.
- BMI 35 or more, or 30 or more with two or more related conditions: hear the surgical option too.
What happens after: keeping the weight off
Obesity behaves like a long-term condition, and each option works only while its effect lasts. In the semaglutide trial extension, people who stopped the injection and the lifestyle programme regained two-thirds of their lost weight within a year. The 2025 review lists weight regain after removal as a limitation of balloons, and ESG trial participants agreed to lifelong dietary limits.
What helps is ordinary: a katori of dal, paneer, eggs or curd at each meal, two rotis rather than four, unsweetened tea, a walk after dinner, sweets kept for occasions, and follow-up visits.
When bariatric surgery is still the better choice
Surgery such as sleeve gastrectomy or gastric bypass gives the largest and longest-lasting weight loss, the 2025 review notes. Indian surgical guidance considers it at a BMI of 35 or more, or 30 or more with two or more obesity-related conditions. INASL describes endoscopic therapy as usually meant for people who do not meet those criteria, are not fit for surgery, or have not lost or kept off weight with lifestyle change.
What’s changing
- Newer medicines. Dual-hormone (GLP-1 plus GIP) medicines such as tirzepatide are in wider use; high cost and unclear treatment duration remain open questions.
- Combined treatment. Endoscopic procedures are being studied together with medicines, to see whether the pair can approach surgical results.
- Liver-focused research. Early studies are measuring liver fat and stiffness after ESG.
Conclusion
Non-surgical weight loss is real medicine, not a slimming package. Lifestyle change underpins every option, medicines work while they are taken, a balloon gives a time-limited push, and ESG offers a more lasting change without surgery. The right fit depends on your BMI, your liver and sugar reports, and how you plan to keep the weight off.
Ask which weight-loss route suits you Weighing a balloon, ESG or injections after years of diets? A consultation can compare the options against your own reports. Dr Sushrut Singh, a gastroenterologist with a DM from ILBS, New Delhi, consults at Fortis Hospital, Sector 62, Noida, and at his clinic in Gaur City 2, Greater Noida West. Call or WhatsApp 093153 54431, and bring your blood reports, any FibroScan result and your medicine list.
Frequently Asked Questions (FAQs)
How much weight will I lose with a balloon or ESG?
Trials report averages: 7-14% of body weight at 6-12 months with a balloon and 13.6% at one year with ESG. Individual results vary, so no one can promise a figure.
Is ESG the same as sleeve gastrectomy?
No. Sleeve gastrectomy is surgery that removes a large part of the stomach. ESG narrows it with stitches placed from inside, through the mouth, and removes nothing.
Can I stop weight-loss injections once I reach my target?
Only with your doctor’s plan. In the semaglutide trial extension, people regained two-thirds of their lost weight within a year of stopping.
Will losing weight help my fatty liver?
Often, yes. Indian liver guidance links 3-5% weight loss with less liver fat and 7-10% with further improvement.
Can I have a balloon if I have a stomach ulcer?
Not while it is active. Ulcers, a large hiatus hernia and active H. pylori infection are listed among reasons not to place a balloon, so they are checked first.